GLP-1 ad war spills into court as Novo Nordisk alleges Eli Lilly ignores science - The Washington Post
- GLP-1 ad war spills into court as Novo Nordisk alleges Eli Lilly ignores science The Washington Post
- Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising CNBC
- Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads | Pharmaceuticals industry The Guardian
- Novo sues Lilly, claiming misleading ads in weight-loss drug battle Reuters
- Novo Sues Rival Lilly Over Alleged False Advertising in Weight-Loss Ads WSJ